About HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe
During the past decade, HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on
average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
A Study to Compare Subcutaneous (SC) Versus Intravenous (IV) Administration of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Early Breast Cancer
2009-10-16
2017-01-24
Completed
596
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe"
#1 collaborator was "Breast International Group" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "Hoffmann-La Roche" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe
According to Clinical.Site data, the most researched conditions in "HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe" are
"Breast Cancer" (2 trials), "Metastatic Breast Cancer" (1 trials), "Neoplasm Metastasis" (1 trials) and "Ovarian Cancer" (1 trials). Many other conditions were trialed in "HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe" in a lesser frequency.
Clinical Trials Intervention Types at HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe
Most popular intervention types in "HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (2 trials), "Docetaxel" (2 trials), "Paclitaxel" (2 trials), "Pertuzumab" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.
Clinical Trials Genders at HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe
The vast majority of trials in "HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe" are
4 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe
Currently, there are NaN active trials in "HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in HELIOS Klinikum Berlin-Buch; Klinik für Gynäkologie und Geburtshilfe, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".